Company news

Roadside Real Estate Plc (LSE:ROAD) news

Roadside Real Estate Plc news releases on 6ix. Latest, Apr 2, 2024: Suspension - Roadside Real Estate plc

View Roadside Real Estate Plc →

Press releases — page 2

Suspension - Roadside Real Estate plc

April 2, 2024

Update on debt refinancing

March 28, 2024

CSS receives first PO & progresses three licences

March 27, 2024

Third joint venture acquisition

March 22, 2024

Partial sale of CSS shareholding for £6.0m

March 20, 2024

Second joint venture acquisition

March 6, 2024

Change of Name to Roadside Real Estate plc

January 30, 2024

Update on debt refinancing and CSS

December 19, 2023

First joint venture acquisition

December 15, 2023

Posting of Circular and Notice of General Meeting

December 13, 2023

Intention to refinance debt facilities

December 4, 2023

Practical completion of second Roadside asset

November 7, 2023

Formation of Roadside Real Estate Joint Venture

October 31, 2023

Trading update

September 29, 2023

CSS Announces Licensing Deal with Mammoth

September 19, 2023

Response to media speculation re CSS

September 11, 2023

Disposal of Workshop Coffee

August 1, 2023

CSS announces new licensing agreement

June 14, 2023

Pub portfolio update

June 9, 2023

Major licensing deal for Cambridge Sleep Sciences

June 6, 2023

Practical completion of first Roadside asset

May 31, 2023

Board Update, Equity Issue & Total Voting Rights

May 15, 2023

BARK Welcomes Brian Dostie as New Vice Presid...

May 1, 2023

Interim results

March 31, 2023

Notice of AGM & Debt Facility Drawing

January 16, 2023

Final results for the year ended 2 July 2022

December 30, 2022

Trading and Strategy Update

November 28, 2022

Acquisition of the Eliot Arms

November 25, 2022

Exchange of Contracts at Saffron Walden, Essex

April 26, 2022

Acquisition of The Coach and Horses

April 1, 2022

Interim Results

March 30, 2022

Appointment of Group Property Director

March 3, 2022

Verso Biosense completes clinical study

March 2, 2022

Board Update

March 1, 2022

Issue of Equity and Total Voting Rights

February 3, 2022

Cambridge Sleep Sciences Announces New Partners

January 25, 2022

Verso Biosense study nears completion

January 18, 2022

Posting of Annual Report & Notice of AGM

January 13, 2022

Final Results for the Year Ended 1 July 2021

December 24, 2021

Second Price Monitoring Extn

December 20, 2021

Exchange of Contracts in Swindon, Wiltshire

December 17, 2021

Price Monitoring Extension

October 27, 2021

Trading Statement

August 10, 2021

New lease for The Ebrington Arms

June 16, 2021

Result of AGM and change of name

May 7, 2021

Cambridge Sleep Sciences signs new partners

April 15, 2021

Verso Biosense signs collaboration agreement

April 8, 2021

Final Results

March 31, 2021

Verso Biosense signs agreement with hospital

March 25, 2021

Cambridge Sleep Sciences partnership announcement

March 11, 2021

← Newer · Older →